✦ LIBER ✦

Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking

✍ Scribed by Beric R. Henderson

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 283 KB
Volume: 27
Category: Article
ISSN: 0265-9247
DOI: 10.1002/bies.20277

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The subcellular location and function of many proteins are regulated by nuclear–cytoplasmic shuttling. BRCA1 and BARD1 provide an interesting model system for understanding the influence of protein dimerization on nuclear transport and localization. These proteins function predominantly in the nucleus to regulate cell cycle progression, DNA repair/recombination and gene transcription, and their export to the cytoplasm has been linked to apoptosis. Germ‐line mutations in the BRCA1/BRCA2 and BARD1 genes predispose to risk of breast/ovarian cancer, and certain mutations impair protein function and nuclear accumulation. BRCA1 and BARD1 shuttle between the nucleus and cytoplasm; however heterodimerization masks the nuclear export signals located within each protein, causing nuclear retention of the BRCA1–BARD1 complex and potentially influencing its role in DNA repair, cell survival and regulation of centrosome duplication. This review discusses BRCA1, BRCA2 and BARD1 subcellular localization with emphasis on regulation of transport by protein dimerization and its functional implications. BioEssays 27:884–893, 2005. © 2005 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Mitochondrial localization, ELK-1 transc

Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins

✍ Anna W. Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

## Abstract BRCA1 is a tumor suppressor gene that is mutated in families with breast and ovarian cancer. Several BRCA1 splice variants are found in different tissues, but their subcellular localization and functions are poorly understood at the moment. We previously described BRCA1 splice variant B

Regulation of intracellular HAP1 traffic

Regulation of intracellular HAP1 trafficking

✍ Juan Rong; Shi-Hua Li; Xiao-Jiang Li 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract A number of proteins are known to interact with huntingtin (htt), the Huntington's disease (HD) protein. Understanding the function of these htt‐associated proteins could help elucidate the pathogenesis of HD and the role that htt plays in the disease process. The present review focuses

Germline mutations of the BRCA1-associat

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

✍ Chiara Ghimenti; Elisa Sensi; Silvano Presciuttini; Isa Maura Brunetti; PierFran 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract BARD1 (BRCA1‐associated RING domain) was identified by yeast two‐hybrid screening as a protein interacting with BRCA1. Somatic and germline mutations of __BARD1__ have been detected in sporadic breast, ovarian, and endometrial cancers. The present study represents the first description

Cancer predisposing missense and protein

Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families

✍ Sylvia De Brakeleer; Jacques De Grève; Remy Loris; Nicolas Janin; Willy Lissens; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 1 views

Fifteen years ago BRCA1 and BRCA2 were reported as high penetrant breast cancer predisposing genes. However, mutations in these genes are found in only a fraction of high risk families. BARD1 is a candidate breast cancer gene, but only a limited number of missense mutations with rather unclear patho

Clinical management of BRCA1- and BRCA2-

Clinical management of BRCA1- and BRCA2-associated breast cancer

✍ Stephen E. Karp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the

Identification of specific BRCA1 and BRC

Identification of specific BRCA1 and BRCA2 variants by DHPLC

✍ Eva Gross; Norbert Arnold; Katharina Pfeifer; Katrin Bandick; Marion Kiechle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views